Evidence map›Paper›PMID 32376308›Full record

SynthesisInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.

Qianwen Zhao, Meng Meng, Rahul Kumar, Yinlian Wu, Jiaofeng Huang, Yunlei Deng, Zhiyuan Weng, Li Yang

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 292 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
292citing papers in PubMed, 4 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

292 citing papers in PubMed, 4 syntheses or guidelines pooled it, 517 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical significance of prognostic nutrition index in hospitalized patients with COVID-19: Results from single-center experience with systematic review and meta-analysis.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Influence of COVID-19 on Clinical Outcomes ofAntibiotics (Basel, Switzerland) · 2026
    Article
  8. Article
  9. COVID-19, the disease that changed the world.Medicine and pharmacy reports · 2026
    Review
  10. Article
  11. Crosstalk betweenFrontiers in immunology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review

232 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Qianwen ZhaoDepartment of Gastroenterology and Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, China.
Meng MengDigestion Center, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Rahul KumarDepartment of Gastroenterology and Hepatology, Changi General Hospital, Singapore.
Yinlian WuLiver Research Center, the First Affiliated Hospitals of Fujian Medical University, Fujian, China.
Jiaofeng HuangLiver Research Center, the First Affiliated Hospitals of Fujian Medical University, Fujian, China.
Yunlei DengDepartment of Nephrology, The Third People's Hospital of Chengdu, Chengdu, China.
Zhiyuan WengCardiovascular department, the First Affiliated Hospitals of Fujian Medical University, Fujian, China. Electronic address: wengzhiyuan@fjmu.edu.cn.
Li YangDepartment of Gastroenterology and Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, China. Electronic address: yangli_hx@scu.edu.cn.
Fujian Medical University · CNCapital Medical University · CNChangi General Hospital · SGChengdu Third People's Hospital · CNFirst Affiliated Hospital of Fujian Medical University · CNSichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCoronavirus Disease 2019 (COVID-19) is a new respiratory and systemic disease which needs quick identification of potential critical patients. This meta-analysis aimed to explore the relationship between lymphocyte count and the severity of COVID-19.

methodsA comprehensive systematic literature search was carried out to find studies published from December 2019 to 22 March 2020 from five databases. The language of literatures included English and Chinese. Mean difference (MD) of lymphocyte count in COVID-19 patients with or without severe disease and odds ratio (OR) of lymphopenia for severe form of COVID-19 was evaluated with this meta-analysis.

resultsOverall 13 case-series with a total of 2282 cases were included in the study. The pooled analysis showed that lymphocyte count was significantly lower in severe COVID-19 patients (MD -0.31×10

conclusionsLymphopenia is a prominent part of severe COVID-19 and a lymphocyte count of less than 1.5×10

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19HumansLymphocyte CountLymphopeniaPandemicsPneumonia, ViralSARS-CoV-2COVID-2019lymphocyte countlymphopenia

Identifiers

PMID32376308
PMCPMC7196544
OpenAlexW3023020711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.